FDA Approved: EPTIFIBATIDE — Supplemental Application (Eugia US LLC)

View source ↗

Summary

FDA approved a supplemental application for the generic drug Eptifibatide filed by Eugia US LLC (ANDA 206127).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Ischemic Heart Disease
• Myocardial Infarction

Drugs mentioned

• EPTIFIBATIDE (EPTIFIBATIDE)

Snippet

SUPPL AP for EPTIFIBATIDE (EPTIFIBATIDE)